Call for papers: Cell and molecular therapy for cardiovascular disorders

BMC Cardiovascular Disorders warmly welcomes submissions to a new article Collection on cell and molecular therapy for cardiovascular disorders.
 Call for papers: Cell and molecular therapy for cardiovascular disorders
Like

BMC Cardiovascular Disorders is calling for submissions to our Collection on cell and molecular therapy for cardiovascular diseases. Scientists from around the globe are investigating/leveraging cell and molecular-based strategies to protect, regenerate, replace, and restore the function of cardiac and vascular tissue. Advances in basic and clinical research have yielded encouraging findings highlighting the promise of such strategies to treat a range of CVDs. However, gaps in our knowledge remain and further research is required to translate findings from basic research into the clinic. 

In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders calls for papers exploring the potential of stem cells, gene editing, tissue engineering, disease modeling, and organoids to improve our understanding of cardiovascular diseases and open new avenues for therapeutic intervention. 

Meet the Guest Editors

Sherin Saheera: University of Massachusetts Chan Medical School, US

Dr Sherin Saheera completed her PhD in India in 2017 and went to the US to pursue her postdoctoral studies. After a year of training at the University of Alabama at Birmingham, she is currently working as a Postdoctoral Associate at the University of Massachusetts, Chan Medical School, where she has been  since January 2019. She has over 18 publications in peer reviewed high impact journals and has been serving as an editorial board member and reviewer for reputed journals. She has also presented papers in several national and international conferences.

Huiliang Zhang: University of Arkansas for Medical Sciences, US
Dr Zhang’s research focuses on cardiac dysfunction in the aging heart with an emphasis on the pathogenic role of elevated proton leak from mitochondria. He explores the strategies for restoring mitochondrial function and stem cell therapies to reverse cardiac dysfunction in preclinical models of aging. Dr. Zhang is the principal investigator of the NIH R35 grant and the American Heart Association (AHA) Career Development Award. Dr. Zhang served in NIH and AHA study sections. He has nearly 40 original publications and has won several national trainee and junior faculty awards.

Submission Guidelines

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cell and molecular therapy for cardiovascular disorders" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

Submission Status: Open   |   Submission Deadline: 21 June 2024

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Cardiovascular Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Cardiovascular Diseases
Health Care
Life Sciences > Health Sciences > Health Care

Related Collections

With collections, you can get published faster and increase your visibility.

Cerebrovascular Disorders

Cerebrovascular disorders comprise a range of distinct pathologies, including ischaemic and haemorrhagic stroke, transient ischaemic attack, and other intracranial vascular disorders (e.g. vascular malformations and unruptured aneurysms), and significantly increase the risk of vascular dementia. Cerebrovascular disorders represent a significant medical and economic challenge which is anticipated to increase in parallel with a global ageing population. The past decade has brought great progress in diagnostic and therapeutic options but more needs to be done to improve the life of patients. Advances in basic science techniques and medical technologies hold great potential to improve the management of cerebrovascular disorders in the coming decades; however, rigorously designed translational research programs are needed to bring novel discoveries to the clinic.

Publishing Model: Open Access

Deadline: Mar 29, 2024

Mechanics and fluid dynamics in cardiovascular disease

BMC Cardiovascular Disorders is calling for submissions to our Collection on Mechanics and fluid dynamics in cardiovascular disease.The study of cardiovascular mechanics and blood flow dynamics can help us understand the mechanisms underlying various cardiovascular diseases, including atherosclerosis, aneurysms, valve dysfunction and heart failure. This approach can address numerous challenges in cardiovascular medicine, including the detection of early-stage disease, risk stratification, the replacement of invasive techniques, and the need for patient-specific treatment planning. However, advances are needed to improve data assimilation methods, model accuracy, reduce the computational complexity of fluid dynamic simulations, and the implementation of flow-related biomarkers of disease into the clinic. To help address this need and support SDG3: Good Health and Wellbeing, BMC Cardiovascular Disorders invites authors to submit articles applying mechanics and fluid dynamics principles in cardiovascular research and medicine.

Publishing Model: Open Access

Deadline: May 28, 2024